You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

corticosteroids therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Olfactory Dysfunction Trial in Shanghai (corticosteroids therapy, Olfactory training)

Recruiting
  • Olfactory Dysfunction
  • corticosteroids therapy
  • Olfactory training
  • Shanghai, Shanghai, China
    Eye & ENT Hospital
Jun 16, 2022

Acute Heart Failure Trial (Dexamethasone, Prednisone)

Not yet recruiting
  • Acute Heart Failure
  • (no location specified)
Mar 30, 2023

COPD Trial in Miami (Bevespi, Bretzri)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Miami, Florida
    University of Miami
Jan 23, 2023

Vocal Fold Nodules Trial in Pittsburgh (Fluticasone propionate, Standard voice therapy)

Recruiting
  • Vocal Fold Nodules
  • Fluticasone propionate
  • Standard voice therapy
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
Jul 8, 2022

Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)

Recruiting
  • Hepatitis, Drug-Induced
  • Mycophenolate Mofetil
  • +3 more
  • Herlev, Copenhagen, Denmark
  • +4 more
Dec 11, 2022

Pemphigus, Dermatologic Disease Trial (RiTUXimab Injection)

Not yet recruiting
  • Pemphigus
  • Dermatologic Disease
  • RiTUXimab Injection
  • (no location specified)
Jun 7, 2023

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting
  • Uncontrolled Asthma
  • Experimental: CHF6001 3200 μg
  • Placebo Comparator: CHF6001 Placebo
  • (no location specified)
Sep 7, 2023

Dermatitis, Atopic Trial in Spain (Ciclosporin)

Recruiting
  • Dermatitis, Atopic
  • Badalona, Barcelona, Spain
  • +8 more
Jan 5, 2023

Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

Recruiting
  • Asthma
  • To compare in both treatment arms the percentage of patients controlled at week 52.
  • Inca, Baleares, Spain
  • +16 more
Jun 16, 2023

Using Specific Tests in Preschool Wheeze to Help us Determine

Active, not recruiting
  • Wheezing
  • Blood eosinophil count
  • +2 more
  • Oxford, United Kingdom
    John Radcliffe Hospital
Oct 10, 2022

Chronic Rhinosinusitis With Nasal Polyps Trial in China (Dupilumab, Placebo, Budesonide)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Beijing, China
  • +9 more
May 31, 2023

Lupus Nephritis, Systemic Lupus Erythematosus (SLE) Trial in Paris (Obinutuzumab administration, Administration of

Recruiting
  • Lupus Nephritis
  • Systemic Lupus Erythematosus (SLE)
  • Obinutuzumab administration
  • +2 more
  • Paris, France
    Internal medicine, Cochin hospital, APHP
Dec 9, 2021

Asthma, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared to

Recruiting
  • Asthma
  • Nonadherence, Medication
  • Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
  • Saint Louis, Missouri
    Washington University in St. Louis School of Medicine
Jan 8, 2023

Allergic Rhinitis, Inflammation, Respiratory Tract Diseases Trial in Guangzhou (Budesonide nasal spray, Placebo)

Completed
  • Allergic Rhinitis
  • +3 more
  • Budesonide nasal spray
  • Placebo
  • Guangzhou, Guangdong, China
    Guangzhou institute of respiratory disease
Mar 6, 2021

Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)

Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura
  • (no location specified)
Aug 8, 2022

aGVHD, Stem Cell Transplant Complications Trial in Beijing (Ruxolitinib 10 mg twice a day combined with Corticosteroids,

Completed
  • aGVHD
  • Stem Cell Transplant Complications
  • Ruxolitinib 10 mg twice a day combined with Corticosteroids
  • +3 more
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 12, 2021

Inpatient COVID-19 Treatments

Active, not recruiting
  • COVID-19
  • Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
  • New York, New York
    Aetion, Inc.
Jan 12, 2023

Allogeneic Disease, GVH - Graft Versus Host Reaction, GVHD, Acute Trial in Paris (Methotrexate, Placebo)

Recruiting
  • Allogeneic Disease
  • +3 more
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Oct 22, 2021

Acute Exacerbation of COPD, Corticosteroid, Morality Trial (Prednisone, Placebo)

Not yet recruiting
  • Acute Exacerbation of COPD
  • +6 more
  • (no location specified)
Jan 13, 2023

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

Heart Rate Variability in Individuals With Duchenne Muscular

Completed
  • Duchenne Muscular Dystrophy
  • Duchenne Muscular Dystrophy group with Deflazacort
  • +3 more
  • (no location specified)
Feb 1, 2021

Atopic Dermatitis Trial in Japan (Tralokinumab, Placebo, Topical corticosteroids (TCS))

Completed
Has Results
  • Atopic Dermatitis
  • Nagoya-shi, Aichi, Japan
  • +24 more
Aug 26, 2022

Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)

Recruiting
  • Rheumatic Arthritis
  • Berlin, Germany
  • +5 more
Mar 1, 2022

Tiotropium and Olodaterol in Comparison to Triple Therapy

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium and Olodaterol (Tio+Olo)
  • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
  • Andover, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

Crohn's Disease Trial in Hamilton, ON (Prednisone, Exclusive Enteral Nutrition)

Terminated
  • Crohn's Disease
  • Hamilton, ON, Ontario, Canada
    McMaster University
Aug 31, 2020